Cargando…
pH-responsive graphene oxide loaded with targeted peptide and anticancer drug for OSCC therapy
Oral squamous cell carcinoma (OSCC) is the most common type of cancer occurring in the oral and maxillofacial regions. Despite of the advances in the diagnosis and treatment, the overall 5-year survival rate has remained about 40%–50% in the past decades. Various nanotechnology-based carrier systems...
Autores principales: | Li, Ran, Gao, Ruifang, Zhao, Yingjiao, Zhang, Fang, Wang, Xiangyu, Li, Bing, Wang, Lu, Ma, Lixin, Du, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382286/ https://www.ncbi.nlm.nih.gov/pubmed/35992794 http://dx.doi.org/10.3389/fonc.2022.930920 |
Ejemplares similares
-
Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
por: Li, Ran, et al.
Publicado: (2021) -
A Targeted and pH-Responsive Nano-Graphene Oxide Nanoparticle Loaded with Doxorubicin for Synergetic Chemo-Photothermal Therapy of Oral Squamous Cell Carcinoma
por: Li, Ran, et al.
Publicado: (2023) -
Schiff-Linked PEGylated Doxorubicin Prodrug Forming pH-Responsive Nanoparticles With High Drug Loading and Effective Anticancer Therapy
por: Song, Jian, et al.
Publicado: (2021) -
Identification of therapeutically potential targets and their ligands for the treatment of OSCC
por: Kumari, Pratima, et al.
Publicado: (2022) -
Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)